| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 34,743 | 32,545 | 28,533 | 30,731 | | Cost of Revenue | 13,084 | 12,618 | 14,530 | 9,749 | | | Gross Profit | 21,659 | 19,927 | 14,003 | 20,982 | | | Operating Expenses | | Research Development | 12,109 | 12,097 | 13,100 | 13,344 | | Selling General and Administrative | 9,877 | 9,880 | 10,702 | 11,123 | | Non Recurring |
-
| 9 | 4,582 | 2,305 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (327) | (2,059) | (14,381) | (5,790) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (120) | (285) | 415 | 2,801 | | Earnings Before Interest And Taxes | (447) | (2,344) | (13,966) | (2,989) | | Interest Expense | 439 | 462 | 433 | 469 | | Income Before Tax | (886) | (2,806) | (14,399) | (3,458) | | Income Tax Expense | 93 | 127 | 172 | 90 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (979) | (2,933) | (14,571) | (3,548) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (979) | (2,933) | (14,571) | (3,548) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($979) | ($2,933) | ($14,571) | ($3,548) |
|
1.52% Nasdaq 0.00%
Income Statement
